The Application Effect of Modified Pressure-Reducing Fixation Protective Nasal Strip in the Nursing Care of Patients Receiving High-Flow Nasal Cannula Therapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Interval Time for Changing the Fixation Strap
研究概览
简要总结
This study was a prospective, randomized controlled trial that included 60 patients receiving high-flow nasal cannula (HFNC) therapy. Participants were randomly divided into two groups: the observation group (n=30), which used a modified decompression fixation protective patch, and the control group (n=30), which received hydrocolloid dressing protection in addition to standard care. The study compared general demographic data, the interval time between changing fixation straps, the times of adjusting the catheter position, the effectiveness of skin management, the number of ineffective oxygenation attempts, the incidence of adverse events, and patient comfort scores between the two groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet the diagnostic criteria for respiratory failure, worsening dyspnea, acute exacerbation of chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, and congestive heart failure.
- •No severe cognitive impairment.
- •Good compliance and being able to actively cooperate with the investigation.
- •No concurrent metabolic diseases.
排除标准
- •Patients with severe respiratory failure, severe arrhythmias, concurrent pneumothorax, coma upon admission, or persistent vomiting.
- •Patients with severe liver failure, kidney failure, or other severe systemic diseases.
- •Patients with severe cognitive impairment who are unable to understand or comply with the study requirements.
- •Patients with severe hemodynamic instability.
- •Patients with allergies to oxygen therapy or protective patch materials.
研究组 & 干预措施
The control group
The control group received standard care plus a hydrocolloid dressing for protection
干预措施: Standard care alone (Device)
The observation group
The observation group employed the modified pressure-reducing fixation protective nasal strip
干预措施: the modified pressure-reducing fixation protective nasal strip (Device)
结局指标
主要结局
Interval Time for Changing the Fixation Strap
时间窗: The time from receiving high-flow nasal cannula (HFNC) therapy to removal as per medical advice. up to a month.
Times of Adjusting the Catheter Position
时间窗: Data were collected every three days from the initiation of high-flow nasal cannula (HFNC) therapy until its removal as per medical advice. up to a month.
Effectiveness of skin management
时间窗: The time from receiving high-flow nasal cannula (HFNC) therapy to removal as per medical advice. up to a month.
The Braden Scale assesses six factors to determine a patient's risk of developing pressure ulcers. Each factor is scored from 1 to 4 (except for activity and friction/shear, which are scored from 1 to 3), with a total possible score of 23. The lower the total score, the higher the risk of pressure ulcers. (Sensory Perception: Assesses the patient's ability to perceive and respond to discomfort or pressure on the skin; Normal sensation: 4 points. Completely unable to sense: 1 point. Moisture: Evaluates the frequency of skin exposure to moisture. Skin stays dry: 4 points; Skin is often moist: 1 point. Activity: Assesses the patient's ability to move. Fully mobile: 4 points; Completely bedridden: 1 point. Mobility: Evaluates the patient's ability to change and control body position. Fully able to move and control: 4 points; Completely unable to move: 1 point. Nutrition: Assesses the patient's nutritional intake. Good nutrition: 4 points; Very poor nutrition: 1 point. Friction and Shear:
Incidence of Ineffective Oxygenation
时间窗: The time from receiving high-flow nasal cannula (HFNC) therapy to removal as per medical advice. up to a month.
次要结局
- Comparison of Comfort Levels(Assessed on the 3th day after the start of the experiment)
- Adverse Event Incidence(The time from receiving high-flow nasal cannula (HFNC) therapy to removal as per medical advice. up to a month.)
研究者
Ying Zhou
Principal Investigator
Wuxi Ninth People's Hospital